Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma

De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma
Conditions:   HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage;   Oropharynx Cancer
Interventions:   Procedure: Transoral robotic surgery;   Drug: Cisplatin – Dose Level 1;   Drug: Cisplatin – Dose Level 2;   Radiation: Dose Level 1;   Radiation: Dose Level 2
Sponsor:   Nebraska Methodist Health System
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 21, 2020 / by / in
Comments